ClinConnect ClinConnect Logo
Search / Trial NCT06683599

SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation

Launched by VINÍCIUS C QUINTÃO, MD, MSC, PHD · Nov 8, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Difficult Intubation Apneic Oxygenation Neonate

ClinConnect Summary

This clinical trial is studying a new approach to help safely place breathing tubes (intubation) in newborns and infants, especially when they have difficulty breathing. Intubation is a critical procedure that can save lives, but it can be tricky, and many babies experience drops in oxygen levels during the process. The researchers want to see if using special tools (called video laryngoscopes) along with extra oxygen can make it easier to intubate these young patients and reduce the risks associated with low oxygen levels.

To participate in this study, babies and infants up to 52 weeks old who need a breathing tube for reasons like surgery or medical treatment could be eligible. However, those who have had challenges with intubation before or who need different methods to secure their airway may not qualify. If enrolled, participants will receive the procedure in a controlled setting, and the research team will closely monitor their progress to ensure their safety. This study aims to improve how we manage breathing difficulties in our youngest patients, making the process safer and more effective.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical procedures.
  • Neonates and infants up to 52 weeks post-conceptual age.
  • Written informed consent provided by legal guardians prior to the intervention.
  • Exclusion Criteria:
  • Prediction of difficult intubation based on physical examination or a history of previous difficult intubation.
  • Requirement for an alternative technique to direct laryngoscopy to secure the airway.
  • Specific conditions, such as congenital heart disease requiring FiO₂ \< 1.0, or cardiopulmonary collapse necessitating advanced life support and intubation for emergency surgical or non-surgical interventions.

About Vinícius C Quintão, Md, Msc, Phd

Dr. Vinícius C. Quintão, MD, MSc, PhD, is a distinguished clinical trial sponsor recognized for his expertise in advancing medical research and innovative therapeutic interventions. With a robust academic background and extensive experience in clinical practice, Dr. Quintão leads multidisciplinary teams in the design and implementation of rigorous clinical trials. His commitment to enhancing patient care through evidence-based methodologies has positioned him as a key contributor in the field, driving forward initiatives that aim to improve health outcomes and contribute to the scientific community.

Locations

Uppsala, , Sweden

Perth, Western Australia, Australia

Copenhagen, , Denmark

Sao Paulo, , Brazil

Patients applied

0 patients applied

Trial Officials

Vinicius C Quintao, MD, MSc, PhD

Principal Investigator

Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported